| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 111.92× | 111.92× | 114.49× | 113.09× | 118.36× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.63× | 1.56× | 2.52× | 2.13× | 1.59× | ||
| 0.54× | 0.54× | 0.56× | 0.50× | 0.40× | ||
| 2.51× | 2.51× | −0.31× | 0.04× | −0.18× | ||
| 2.78× | 2.78× | −0.67× | 0.53× | −0.30× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 118.36 | 113.09 | 114.49 | 111.92 | 111.92 | |
| Working Capital Turnover | 1.59 | 2.13 | 2.52 | 1.56 | 1.63 | |
| Asset Turnover | 0.40 | 0.50 | 0.56 | 0.54 | 0.54 | |
| Cash Conversion (CFO/Net Income) | -0.18 | 0.04 | -0.31 | 2.51 | 2.51 | |
| CFO/EBITDA | -0.30 | 0.53 | -0.67 | 2.78 | 2.78 |